van Es Charles 4

4 · Vita Coco Company, Inc. · Filed May 11, 2026

AI-generated summary of this filing

Updated May 11, 2026

Vita Coco CCO Charles van Es Sells 8,561 Shares

What Happened

Charles van Es, Chief Commercial Officer of Vita Coco Company, sold 8,561 shares of common stock on May 8, 2026 at $70.00 per share, for total proceeds of $599,270. The reported disposition is coded as a sale (S) and was effected pursuant to a Rule 10b5-1 trading plan.

Key Details

Transaction date and price: 2026-05-08, 8,561 shares @ $70.00 each.
Total value: $599,270.
Shares owned after transaction: not specified in the provided filing details.
Notable footnotes: F1 indicates the sale was made under a Rule 10b5-1 plan. Other footnotes (F2–F8) describe various option vesting schedules; F5 notes 14,025 option shares vested on Feb 20, 2026.
Filing timeliness: Form 4 was filed on 2026-05-11 reporting the 2026-05-08 transaction; this appears to be a timely filing (within the standard two business days).

Context

Sales executed under a Rule 10b5-1 plan are pre-arranged, scheduled trades and do not necessarily reflect the insider’s current view of the company. The filing also documents several option vesting provisions (including a recent vesting event in February 2026) that may explain the availability of shares for sale. As with all insider sales, this is factual disclosure rather than a buy/sell recommendation.

Form 4

Period: 2026-05-08

Chief Commercial Officer

Transactions

Holdings

Non-Qualified Stock Option (Right to Buy)
[F2]
Exercise: $10.18Exp: 2030-02-10→ Common Stock (53,750 underlying)
53,750
Non-Qualified Stock Option (Right to Buy)
[F2]
Exercise: $10.18Exp: 2031-01-11→ Common Stock (27,300 underlying)
27,300
Non-Qualified Stock Option (Right to Buy)
[F3]
Exercise: $15.00Exp: 2031-10-21→ Common Stock (58,043 underlying)
58,043
Non-Qualified Stock Option (Right to Buy)
[F4]
Exercise: $15.36Exp: 2032-08-15→ Common Stock (42,980 underlying)
42,980
Non-Qualified Stock Option (Right to Buy)
[F5]
Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,025 underlying)
14,025
Non-Qualified Stock Option (Right to Buy)
[F6]
Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,205 underlying)
14,205
Non-Qualified Stock Option (Right to Buy)
[F7]
Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying)
8,746
Non-Qualified Stock Option (Right to Buy)
[F8]
Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
13,218

Footnotes (8)

[F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
[F2]The stock option is fully vested and currently exercisable.
[F3]The stock option vests in four equal annual installments beginning on November 27, 2022.
[F4]The stock option vests in three equal annual installments beginning on August 15, 2025.
[F5]The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
[F6]The stock options vest in four annual equal installments beginning on March 10, 2024.
[F7]The stock option vests in four equal annual installments beginning on March 4, 2025.
[F8]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

Signature

/s/ Alison Klein, attorney-in-fact for Charles van Es|2026-05-11

1 file